DNM1L and pulmonary arterial hypertension: Pharmacological enhancement of the inactive form of DRP1, pDRP6S637, by treprostinil, a prostacyclin analog, also increases mitochondrial fusion in PAH PASMC (Abu-Hanna et al., 2018).